Can You Get Pregnant With Low AMH? Expert Insights and Real Options

Author : ferti health | Published On : 08 Jul 2026

For many women, receiving a low AMH result during a fertility workup feels like a door closing. The number on the report seems final — a verdict rather than a data point. But fertility specialists consistently emphasize one important truth: AMH is a measure of ovarian reserve, not a measure of your ability to get pregnant.

Women around the world conceive naturally and through assisted reproduction every day despite low AMH readings. Understanding what this hormone actually tells you — and what it does not — is the first step toward making informed decisions about your fertility journey.

What Is AMH and What Does It Actually Measure

Anti-Müllerian Hormone, commonly referred to as AMH, is a protein hormone produced by the granulosa cells in the small follicles of the ovaries. The level of AMH in your blood gives doctors an estimate of how many eggs remain in your ovaries — a concept known as ovarian reserve.

Unlike many other hormonal markers used in fertility testing, AMH levels remain relatively stable throughout the menstrual cycle. This means a blood test can be taken on any day of the cycle and still provide a reliable reading. That consistency has made AMH one of the most commonly used markers in fertility assessments over the past two decades.

However, what AMH does not measure is the quality of your eggs. This distinction is critical. A woman can have a low AMH — suggesting fewer eggs — while still having eggs of perfectly good quality. Conversely, a woman with a normal or high AMH can have eggs with chromosomal abnormalities that prevent successful conception or healthy pregnancy. AMH tells you about quantity, not quality.

What Is Considered a Low AMH Level

AMH levels are measured in nanograms per milliliter (ng/mL) or picomoles per liter (pmol/L), depending on the laboratory and country. Reference ranges vary slightly between labs, but general clinical guidelines classify AMH levels as follows:

A reading above 1.0 ng/mL is generally considered within a normal to adequate range for reproductive-age women. Readings between 0.5 and 1.0 ng/mL are considered low but not critically so. Anything below 0.5 ng/mL is typically classified as very low, and readings below 0.16 ng/mL may indicate severely diminished ovarian reserve.

Age plays a significant role in interpreting these numbers. A 38-year-old woman with an AMH of 0.8 ng/mL is in a different clinical situation than a 28-year-old with the same reading. Doctors always interpret AMH in the context of age, antral follicle count (AFC) — the number of small follicles visible on ultrasound — and other hormonal markers such as FSH and estradiol.

Can a Woman With Low AMH Still Get Pregnant Naturally

Yes — and this happens more often than many women expect after receiving a low AMH diagnosis. Several published studies have demonstrated that AMH level alone is a poor predictor of natural conception in women who are actively trying to conceive.

A widely cited study published in the Journal of Clinical Endocrinology and Metabolism followed women aged 30 to 44 who were trying to conceive naturally. The study found no statistically significant difference in natural conception rates between women with low AMH and those with normal AMH levels within the same age group. This finding challenged the assumption that low AMH automatically translates to reduced fertility in women who are still ovulating regularly.

What matters most for natural conception is whether ovulation is occurring and whether the eggs being released are chromosomally normal. A woman with a low AMH who is ovulating regularly still has a meaningful chance of conceiving naturally, particularly if she is under 35 years of age and has no other fertility-related conditions such as blocked tubes, endometriosis, or a partner with compromised sperm quality.

That said, low AMH does suggest a smaller window of time. Because ovarian reserve declines with age for all women — and women with low AMH may experience this decline more rapidly — fertility specialists typically advise against prolonged waiting periods before seeking an evaluation or considering assisted reproduction.

How Low AMH Affects IVF and Assisted Reproduction

Where low AMH has the most direct clinical impact is in the context of in vitro fertilization (IVF). During an IVF cycle, the goal is to stimulate the ovaries to produce multiple eggs simultaneously, which are then retrieved, fertilized in a laboratory, and developed into embryos for transfer.

Women with low AMH tend to respond less robustly to ovarian stimulation. This is referred to as poor ovarian response (POR). In practical terms, it means that an IVF cycle may retrieve fewer eggs than expected — sometimes just one, two, or three mature eggs rather than the eight to fifteen eggs retrieved in a typical response.

Fewer eggs mean fewer embryos, which reduces the number of options available for transfer and reduces the statistical chances of a successful outcome per cycle. However, it does not eliminate the possibility of success. Fertility clinics around the world report successful pregnancies and healthy births from IVF cycles that retrieved only one or two eggs.

Several protocols have been developed specifically to optimize outcomes for women with diminished ovarian reserve. These include modified stimulation protocols using different medication combinations, natural or minimal stimulation IVF — which works with the body's natural cycle rather than trying to force a high egg yield — and the accumulation of embryos across multiple cycles before transfer.

The Role of Egg Quality in Low AMH Cases

Because AMH does not measure egg quality, women with low AMH and good egg quality — which is more likely in younger women — have considerably better prospects than older women with the same AMH reading.

Egg quality is fundamentally about chromosomal integrity. As women age, the likelihood of chromosomal errors in eggs increases significantly. These errors are the primary cause of failed implantation and early miscarriage. A 32-year-old woman with very low AMH but naturally good egg quality for her age has a meaningfully better chance of a successful pregnancy — natural or assisted — than a 42-year-old woman with the same AMH level.

Preimplantation Genetic Testing (PGT), offered alongside IVF, can screen embryos for chromosomal abnormalities before transfer. For women with low AMH who produce only a small number of embryos per cycle, PGT allows clinicians to identify which embryos are chromosomally normal — potentially improving the outcome of a single transfer significantly.

Medical Options for Women With Low AMH

Fertility medicine offers several pathways for women with low AMH who wish to conceive. The most appropriate path depends on age, the degree of AMH reduction, overall health, and personal preferences.

Intrauterine Insemination (IUI)

For women with low but not critically low AMH who are ovulating and have no other significant fertility barriers, IUI is sometimes considered as a first-line assisted option. IUI involves placing prepared sperm directly into the uterus at the time of ovulation, reducing the distance sperm must travel and increasing the chances of fertilization.

IUI is less invasive and less expensive than IVF, making it an accessible starting point. However, its success rates are lower than IVF, and for women with significantly diminished ovarian reserve, reproductive endocrinologists often recommend moving directly to IVF to avoid losing time.

In Vitro Fertilization (IVF)

IVF remains the most effective assisted reproductive technology available for women with low AMH. While response to stimulation may be limited, the ability to retrieve and fertilize eggs outside the body — and to monitor embryo development closely — gives IVF a meaningful advantage over less controlled approaches.

Some clinics specialize in managing poor ovarian response and have developed institutional expertise in protocols that maximize outcomes for this specific group of patients. Seeking a clinic with documented experience in low AMH or poor ovarian response cases is a worthwhile step.

Donor Eggs

For women whose AMH is severely low and who are not responding to stimulation, or for older women where egg quality is also a concern, donor egg IVF is an option that offers high success rates. In this process, eggs from a younger, screened donor are fertilized with the partner's or donor sperm, and the resulting embryo is transferred to the recipient's uterus.

Donor egg IVF success rates are largely determined by the age and health of the egg donor rather than the recipient, which is why this pathway can be effective even for women in their 40s with very low ovarian reserve. The decision to pursue donor eggs is deeply personal and involves emotional, ethical, and logistical considerations that go beyond the medical discussion.

Fertility Preservation

For younger women who receive a low AMH result before they are ready to conceive, egg or embryo freezing offers a way to preserve reproductive options. Eggs retrieved now — when they are younger and of better quality — can be stored for use in future IVF cycles. This is particularly relevant for women in their late 20s or early 30s who have a low AMH and want to prioritize their career or personal circumstances before starting a family.

Lifestyle Factors That May Support Ovarian Health

While no lifestyle change can reverse a low AMH or regenerate egg cells that have been lost, some research suggests that certain factors may support overall ovarian health and egg quality in women with diminished reserve.

Avoiding smoking is one of the most evidence-backed recommendations. Smoking has been directly linked to accelerated ovarian aging and lower AMH levels. Women who smoke and have low AMH are advised strongly to quit — not only for reproductive health but for overall wellbeing.

Maintaining a healthy body weight is also associated with better reproductive outcomes. Both significant underweight and obesity can disrupt hormonal balance and ovulation patterns, compounding the challenges of low ovarian reserve.

Reducing oxidative stress through a diet rich in antioxidants — found in colorful vegetables, fruits, nuts, and whole grains — may support egg quality, though direct evidence linking diet to AMH levels specifically is still limited. Some fertility specialists recommend Coenzyme Q10 (CoQ10) supplementation, citing its role in mitochondrial function within egg cells, though large-scale clinical trials confirming its efficacy are still ongoing.

Managing chronic stress is frequently mentioned in fertility discussions. While stress alone is unlikely to be the primary driver of low AMH, chronic psychological stress does affect hormonal patterns and overall health. Practices such as mindfulness, moderate exercise, and adequate sleep are broadly beneficial.

It is important to approach these lifestyle factors with realistic expectations. They are supportive measures, not cures. Women with low AMH should focus on working with a qualified reproductive endocrinologist rather than delaying medical consultation in favor of lifestyle interventions alone.

Emotional Aspects of a Low AMH Diagnosis

Receiving a low AMH result can be emotionally destabilizing, particularly for women who have only recently begun thinking about fertility or who have been trying to conceive for some time. The diagnosis often triggers grief, anxiety, and a sense of urgency that can be difficult to manage.

Fertility counseling and psychological support have become increasingly recognized as important components of fertility care. Many fertility clinics now offer or recommend counseling services specifically for patients navigating diagnoses like diminished ovarian reserve. Connecting with a counselor experienced in reproductive health issues can help women and their partners process the diagnosis, make clearer decisions, and sustain emotional resilience through treatment.

Online and in-person communities of women who have experienced low AMH and gone on to conceive — naturally or through treatment — can also provide perspective and support. Hearing real stories from women who have navigated this journey successfully does not change the medical facts, but it does remind women that the statistics represent possibilities, not certainties.

When to Seek a Second Opinion

Fertility medicine involves clinical judgment, and not all specialists interpret AMH results or manage poor ovarian response in the same way. If a clinic tells you that pregnancy is impossible due to your AMH level, seeking a second opinion from a reproductive endocrinologist at a different center is entirely reasonable and often advisable.

Some clinics are more experienced with low AMH cases and may offer different protocols, approaches, or perspectives that open up options you were not previously aware of. A second opinion is not a sign of distrust — it is a standard and sensible part of navigating a complex medical situation.

Conclusion

A low AMH result is meaningful clinical information, but it is not a sentence. Women with low AMH conceive naturally, succeed with IVF, and build families through donor eggs and other pathways every day. The hormone tells one part of the story — the size of the remaining egg pool — while leaving the most important chapters still unwritten.

The most productive response to a low AMH diagnosis is informed action: consulting a reproductive endocrinologist, understanding your full fertility picture including egg quality markers, comparing your options across natural conception, IUI, IVF, and egg donation, and making decisions based on your complete clinical profile rather than a single number.

Your AMH level is where the conversation begins — not where it ends.